| scholarly article | Q13442814 |
| P50 | author | Michael Fehlings | Q26720732 |
| P2093 | author name string | Reaz Vawda | |
| Stuart D Faulkner | |||
| P2860 | cites work | Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc | Q24623575 |
| Cellular treatments for spinal cord injury: the time is right for clinical trials | Q24630772 | ||
| Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice | Q24635187 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | Q26269888 | ||
| Induction of human neuronal cells by defined transcription factors | Q26269896 | ||
| Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. | Q47593680 | ||
| Comparison of adult neurospheres derived from different origins for treatment of rat spinal cord injury | Q47941333 | ||
| Dorsal spinal cord neuroepithelium generates astrocytes but not oligodendrocytes | Q48453540 | ||
| Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. | Q48525862 | ||
| Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain | Q48572358 | ||
| Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells | Q48713811 | ||
| Conditional gene expression in human embryonic stem cells. | Q50695689 | ||
| In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. | Q50776286 | ||
| Restoring stem cell function in aged tissues by direct reprogramming? | Q50801368 | ||
| Transplantation of human neural stem cells for spinal cord injury in primates. | Q51527726 | ||
| Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. | Q51825556 | ||
| Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. | Q52599671 | ||
| The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived Mesenchymal stem cells. | Q53165068 | ||
| c-Myc is dispensable for direct reprogramming of mouse fibroblasts. | Q55049543 | ||
| Cordotomy for patients with thoracic malignant astrocytoma | Q55463808 | ||
| Cell-based transplantation strategies to promote plasticity following spinal cord injury | Q57839271 | ||
| The Efficient Generation of Induced Pluripotent Stem (iPS) Cells from Adult Mouse Adipose Tissue-Derived and Neural Stem Cells | Q58883595 | ||
| Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage | Q71815680 | ||
| Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord | Q73226161 | ||
| Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord | Q84110586 | ||
| Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord | Q84465627 | ||
| Immunogenicity of induced pluripotent stem cells | Q84949816 | ||
| Geron trial resumes, but standards for stem cell trials remain elusive | Q85190781 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
| In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state | Q29614212 | ||
| Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| Induced pluripotent stem cells generated without viral integration | Q29614343 | ||
| Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
| Direct generation of functional dopaminergic neurons from mouse and human fibroblasts | Q29616184 | ||
| Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 | ||
| Somatic coding mutations in human induced pluripotent stem cells | Q29616798 | ||
| piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 | ||
| Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease | Q29619506 | ||
| Genetic engineering of human pluripotent cells using TALE nucleases | Q29619830 | ||
| Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats | Q30581117 | ||
| Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury | Q33515283 | ||
| Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells | Q33618981 | ||
| Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord | Q33649636 | ||
| Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells | Q33649644 | ||
| Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency | Q33732735 | ||
| Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. | Q33774561 | ||
| Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury | Q34004845 | ||
| Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells | Q34022185 | ||
| Epidemiology, demographics, and pathophysiology of acute spinal cord injury | Q34110738 | ||
| Direct reprogramming of mouse fibroblasts to neural progenitors | Q34180572 | ||
| Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine | Q34181340 | ||
| Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions | Q34204810 | ||
| Zfp296 is a novel, pluripotent-specific reprogramming factor | Q34224961 | ||
| Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 | ||
| Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 | ||
| Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives | Q34264915 | ||
| Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI | Q34285940 | ||
| The generation of definitive neural stem cells from PiggyBac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway | Q34293770 | ||
| Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions | Q34321448 | ||
| Generation of oligodendroglial cells by direct lineage conversion. | Q34339119 | ||
| Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. | Q34339127 | ||
| Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. | Q34373886 | ||
| Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype | Q34400430 | ||
| Microarray-based analysis of microRNA expression in breast cancer stem cells | Q34499082 | ||
| Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. | Q34506743 | ||
| CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells | Q34630333 | ||
| Generation of human-induced pluripotent stem cells | Q34792230 | ||
| Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury | Q34871124 | ||
| Variation in the safety of induced pluripotent stem cell lines | Q34991636 | ||
| Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape | Q35348017 | ||
| A functionally characterized test set of human induced pluripotent stem cells | Q35588556 | ||
| Confirming an experimental therapy prior to transfer to humans: what is the ideal? | Q35743272 | ||
| Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model | Q35809643 | ||
| Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics | Q36688373 | ||
| Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials | Q36688383 | ||
| Current status of experimental cell replacement approaches to spinal cord injury | Q37110227 | ||
| Generation of integration-free and region-specific neural progenitors from primate fibroblasts | Q37205314 | ||
| Derivation of induced pluripotent stem cells from pig somatic cells | Q37233718 | ||
| Generation of induced pluripotent stem cell lines from Tibetan miniature pig. | Q37285271 | ||
| Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon | Q37315987 | ||
| New ISSCR guidelines underscore major principles for responsible translational stem cell research | Q37337489 | ||
| Olfactory ensheathing cells from the nose: Clinical application in human spinal cord injuries | Q37787441 | ||
| Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases. | Q37799382 | ||
| Adult stem cell transplants for spinal cord injury repair: current state in preclinical research. | Q37863186 | ||
| Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone | Q37879267 | ||
| Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. | Q38040207 | ||
| Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives | Q38070021 | ||
| Conversion of mouse and human fibroblasts into functional spinal motor neurons | Q38651033 | ||
| Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells. | Q39513245 | ||
| Combination of multifaceted strategies to maximize the therapeutic benefits of neural stem cell transplantation for spinal cord repair | Q39577550 | ||
| A safer stem cell: inducing pluripotency | Q39802771 | ||
| Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. | Q40216832 | ||
| Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. | Q40242020 | ||
| Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus | Q40278109 | ||
| Transplantation of embryonic stem cell-derived neural stem cells for spinal cord injury in adult mice | Q40340069 | ||
| Introduction of the MASH1 gene into mouse embryonic stem cells leads to differentiation of motoneuron precursors lacking Nogo receptor expression that can be applicable for transplantation to spinal cord injury | Q40348581 | ||
| Cell adhesion molecule l1-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury | Q40388043 | ||
| Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation | Q40493282 | ||
| Origins of spinal cord oligodendrocytes: possible developmental and evolutionary relationships with motor neurons. | Q41140453 | ||
| Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice | Q41813638 | ||
| The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds | Q41875141 | ||
| The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. | Q42557022 | ||
| Transplantation of GABAergic neurons from ESCs attenuates tactile hypersensitivity following spinal cord injury. | Q42905002 | ||
| Predifferentiated embryonic stem cells promote functional recovery after spinal cord compressive injury | Q42989593 | ||
| Decreased BDNF signalling in transgenic mice reduces epileptogenesis | Q43910666 | ||
| In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord | Q44182017 | ||
| Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. | Q44848574 | ||
| Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? | Q44947589 | ||
| Comparison between fetal spinal-cord- and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury | Q45265200 | ||
| Steady advance of stem cell therapies: report from the 2011 World Stem Cell Summit, Pasadena, California, October 3-5. | Q45960691 | ||
| Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells | Q46350398 | ||
| Migration and distribution of bone marrow stromal cells in injured spinal cord with different transplantation techniques | Q46673439 | ||
| Transplantation of apoptosis-resistant embryonic stem cells into the injured rat spinal cord | Q46726422 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | pluripotency | Q1894941 |
| P304 | page(s) | 500-508 | |
| P577 | publication date | 2013-08-13 | |
| P1433 | published in | World Neurosurgery | Q26853866 |
| P1476 | title | Adult-derived pluripotent stem cells | |
| P478 | volume | 82 |
Search more.